ClinicalTrials.gov
ClinicalTrials.gov Menu

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00885066
Recruitment Status : Completed
First Posted : April 21, 2009
Last Update Posted : February 10, 2015
Sponsor:
Information provided by (Responsible Party):
Centre Antoine Lacassagne

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2009
  Actual Study Completion Date : October 2009